PDCD1 and neoplasm: To specifically redirect T cells to FAP+ tumor cells supplied with a T cell-restricted PD-1/PD-L1 blockade, we developed a Nb-TriTE antibody by fusing an anti-PD-1 Nb to a Nb-BiTE molecule targeting FAP with a flexible (Gly4Ser)3 linker.